Showing results (801-810 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|April 12, 2017
Ramucirumab in the treatment of non-small cell lung cancerOscar Arrieta, Zyanya Lucia Zatarain-Barrón, Andrés F Cardona, et al.Expert Opinion on Drug Safety|April 29, 2014
Panitumumab safety for treating colorectal cancerStefan Stremitzer, Ana Sebio, Sebastian Stintzing, et al.Expert Opinion on Drug Safety|April 11, 2014
Serotonergic antidepressants and perioperative bleeding risk: a systematic reviewArtin A Mahdanian, Soham Rej, Simon L Bacon, et al.Expert Opinion on Drug Safety|March 7, 2014
Painful decision-making at FDALewis S Nelson, Jeanmarie Perrone, David N JuurlinkExpert Opinion on Drug Safety|March 7, 2014
Prospects for MEK inhibitors for treating cancerJuan Martin-Liberal, Laura Lagares-Tena, James LarkinExpert Opinion on Drug Safety|March 10, 2017
The safety of vedolizumab for the treatment of ulcerative colitisGregor Novak, Pieter Hindryckx, Reena Khanna, et al.Expert Opinion on Drug Safety|October 11, 2016
Monitoring safety and use of old and new treatment options for type 2 diabetic patients: a two-year (2013-2016) analysisChristian Leporini, Rosanna Piro, Francesco Ursini, et al.Expert Opinion on Drug Safety|November 24, 2016
The safety profile of monoclonal antibodies for chronic lymphocytic leukemiaAnna Korycka-Wołowiec, Dariusz Wołowiec, Tadeusz RobakExpert Opinion on Drug Safety|May 6, 2014
Asenapine review, part II: clinical efficacy, safety and tolerabilityLeslie CitromeExpert Opinion on Drug Safety|October 15, 2016
The safety of anti PD-1 therapeutics for the treatment of melanomaEgle Ramelyte, Sabrina A Schindler, Reinhard DummerPageof 282